PURPOSE: To assess retinal blood flow in patients with central serous chorioretinopathy (CSR). METHODS: The hospital-based observational comparative study included a study group with 12 patients (age: 45 ± 13 years) with an acute onset of CSR and a control group of 12 subjects matched for age and gender with the study group. The diagnosis was substantiated by fluorescein angiography and optical coherence tomography. All study participants underwent measurement of retinal blood perfusion using the retinal function imager (RFI). RESULTS: The retinal blood flow velocity in the retinal veins was significantly lower in the study group than in the control group (2.76 ± 0.53 mm/s versus 3.33 ± 0.76 mm/s; p = 0.03).The difference between the study group and control group was more marked for the larger retinal veins (2.87 ± 0.51 mm/s versus 3.47 ± 0.48 mm/s; p = 0.001) than for the smaller veins (2.69 ± 0.53 mm/s versus 3.42 ± 1.05 mm/s; p = 0.04). Both groups did not differ significantly in the data of the retinal arterial flow velocities. CONCLUSIONS: The data suggest an abnormal retinal venous blood flow regulation in patients with active CSR.
PURPOSE: To assess retinal blood flow in patients with central serous chorioretinopathy (CSR). METHODS: The hospital-based observational comparative study included a study group with 12 patients (age: 45 ± 13 years) with an acute onset of CSR and a control group of 12 subjects matched for age and gender with the study group. The diagnosis was substantiated by fluorescein angiography and optical coherence tomography. All study participants underwent measurement of retinal blood perfusion using the retinal function imager (RFI). RESULTS: The retinal blood flow velocity in the retinal veins was significantly lower in the study group than in the control group (2.76 ± 0.53 mm/s versus 3.33 ± 0.76 mm/s; p = 0.03).The difference between the study group and control group was more marked for the larger retinal veins (2.87 ± 0.51 mm/s versus 3.47 ± 0.48 mm/s; p = 0.001) than for the smaller veins (2.69 ± 0.53 mm/s versus 3.42 ± 1.05 mm/s; p = 0.04). Both groups did not differ significantly in the data of the retinal arterial flow velocities. CONCLUSIONS: The data suggest an abnormal retinal venous blood flow regulation in patients with active CSR.
Authors: Hong Jiang; Delia Cabrera Debuc; Tatjana Rundek; Byron L Lam; Clinton B Wright; Meixiao Shen; Aizhu Tao; Jianhua Wang Journal: Microvasc Res Date: 2013-06-24 Impact factor: 3.514
Authors: Min Li; Ye Yang; Hong Jiang; Giovanni Gregori; Luiz Roisman; Fang Zheng; Bilian Ke; Dongyi Qu; Jianhua Wang Journal: Am J Ophthalmol Date: 2016-11-04 Impact factor: 5.258
Authors: Jay Chhablani; Dirk-Uwe Bartsch; Lingyun Cheng; Laura Gomez; Rayan A Alshareef; Sami S Rezeq; Sunir J Garg; Zvia Burgansky-Eliash; William R Freeman Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-05-23 Impact factor: 3.117
Authors: Jing Tian; Gábor Márk Somfai; Thalmon R Campagnoli; William E Smiddy; Delia Cabrera Debuc Journal: Microvasc Res Date: 2015-11-11 Impact factor: 3.514
Authors: Jin Zhou; Min Li; Wan Chen; Ye Yang; Liang Hu; Liang Wang; Hong Jiang; Jianhua Wang Journal: J Ophthalmol Date: 2017-07-05 Impact factor: 1.909